Publication PMID: 40829888

Merrill JT, Saxena A, Aringer M, Tanaka Y, Zeng X, Cheng L, Doan TT, D'Cruz D, Masri KR, D'Silva KM. Efficacy and safety of upadacitinib as monotherapy or combined with elsubrutinib for the treatment of systemic lupus erythematosus: results through 104 weeks in a long-term extension study. RMD Open 11, 2025 August, PMID: 40829888, PMCID: PMC12366599